Capital Square, LLC Gilead Sciences, Inc. Transaction History

Capital Square, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $194,784 - $244,086	-3,363 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $64 - $73	-1 Reduced 0.03%	3,363 $242,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $7,235 - $7,905	-114 Reduced 3.28%	3,364 $230,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $12,668 - $15,928	-204 Reduced 5.54%	3,478 $219,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $14,323 - $16,632	-198 Reduced 5.1%	3,682 $283,000
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $5,448 - $6,979	87 Added 2.29%	3,880 $290,000
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $233,724 - $257,089	3,793 New	3,793 $246,000

2,012

995M

10.1M

8.8M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Capital Square, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Square, LLC with notifications on news.